Table 1 Characteristics of the study population (n = 51)
Gender, male | 39 (77) |
|---|---|
Age, years, median (range) | 74 (65‒89) |
Charlson comorbidity index, median (range) | 5 (2–9) |
Time in haemodialysis, months, median (range) | 8 (0–108) |
Urea clearance, Kt/V | 1.47 ± 0.29 |
Arteriovenous fistula | 29 (57) |
Haemodialysis catheter | 22 (43) |
Diagnosis | |
Glomerulonephritis | 3 (6) |
Nephrosclerosis | 18 (35) |
Diabetic nephropathy | 7 (14) |
Post-renal diseasea | 8 (16) |
Otherb | 8 (16) |
Unknown | 7 (14) |
Medications | |
Diuretic drugs | 38 (75) |
Statins | 31 (61) |
Beta-blockers | 29 (57) |
Proton-pump inhibitors | 19 (37) |
Analgesics | 17 (34) |
ACE inhibitorc/angiotensin II receptor antagonist | 14 (28) |
Warfarin | 11 (22) |
Benzodiazepines | 7 (14) |
Tricyclic antidepressants | 3 (6) |
Number of medications, median (25th–75th percentile) | 13 (12–14) |